John Collinge
Oprichter bij D-Gen Ltd.
Actieve functies van John Collinge
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
D-Gen Ltd.
 D-Gen Ltd. BiotechnologyHealth Technology D-Gen Ltd. develops technologies for detection and prevention of prion diseases. The firm offers services that include prion reduction studies, in-process validation and contract sample testing. The company was founded in by John Collinge on November 19, 1998 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 19-11-1998 | - |
| Oprichter | 19-11-1998 | - | |
| University College London | Corporate Officer/Principal | - | - |
| The National Hospital for Neurology & Neurosurgery | Corporate Officer/Principal | - | - |
Loopbaan van John Collinge
Eerdere bekende functies van John Collinge
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | - | - |
| Imperial College London | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
| Verenigd Koninkrijk | 6 |
Operationeel
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
| Founder | 1 |
Sectoraal
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
D-Gen Ltd.
D-Gen Ltd. BiotechnologyHealth Technology D-Gen Ltd. develops technologies for detection and prevention of prion diseases. The firm offers services that include prion reduction studies, in-process validation and contract sample testing. The company was founded in by John Collinge on November 19, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| The National Hospital for Neurology & Neurosurgery |
- Beurs
- Insiders
- John Collinge
- Ervaring
